Literature DB >> 16373087

Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.

Katell Beauvais1, Alain Furby, Philippe Latour.   

Abstract

Charcot-Marie-Tooth disease is a genetically heterogeneous group of neuropathies. In the demyelinating form of Charcot-Marie-Tooth disease with dominant inheritance, five genes have been incriminated: PMP22, MPZ, LITAF/SIMPLE, EGR2 (CMT1A to D), and GJB1 (CMTX). Here, we report clinical, electrophysiological and molecular genetic studies in a family with a Charcot-Marie-Tooth disease variable phenotype, ranging from asymptomatic to moderately affected. The absence of male-to-male transmission as well as the results of systematic electrophysiological studies suggested a CMTX secondary to a GJB1 mutation. Screening for mutations in the coding regions of PMP22, MPZ, EGR2 and GJB1 was negative. We identified (1) a LITAF/SIMPLE substitution (T49M), absent in 1000 control chromosomes, but which was thought to be a polymorphism because of discrepancies of segregation when considering the results of electrophysiology; and (2) a novel substitution T>C in the P2 promoter of GJB1 at position -529, in the SOX10 binding site S2. The transmission of this second mutation was consistent with the electrophysiological data. We emphasise the role of electrophysiological studies that help to discriminate between asymptomatic subjects and that bring some additional valuable data to the genetic approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373087     DOI: 10.1016/j.nmd.2005.09.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

Review 1.  How to assess the pathogenicity of mutations in Charcot-Marie-Tooth disease and other diseases?

Authors:  Andrzej Kochański
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

Review 3.  How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?

Authors:  Kleopas A Kleopa; Charles K Abrams; Steven S Scherer
Journal:  Brain Res       Date:  2012-07-06       Impact factor: 3.252

Review 4.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

5.  LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth.

Authors:  J Zhou; Z Yang; T Tsuji; J Gong; J Xie; C Chen; W Li; S Amar; Z Luo
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

Review 6.  Molecular mechanisms of inherited demyelinating neuropathies.

Authors:  Steven S Scherer; Lawrence Wrabetz
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

7.  Negative regulation of Bmi-1 by AMPK and implication in cancer progression.

Authors:  Deqiang Huang; Xiaoling He; Junrong Zou; Pei Guo; Shanshan Jiang; Nonghua Lv; Yuriy Alekseyev; Lingyu Luo; Zhijun Luo
Journal:  Oncotarget       Date:  2016-02-02

8.  Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT.

Authors:  Pedro J Tomaselli; Alexander M Rossor; Alejandro Horga; Zane Jaunmuktane; Aisling Carr; Paola Saveri; Giuseppe Piscosquito; Davide Pareyson; Matilde Laura; Julian C Blake; Roy Poh; James Polke; Henry Houlden; Mary M Reilly
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

9.  Novel EGR2 variant that associates with Charcot-Marie-Tooth disease when combined with lipopolysaccharide-induced TNF-α factor T49M polymorphism.

Authors:  Maria Empar Blanco-Cantó; Nikiben Patel; Sergio Velasco-Aviles; Angeles Casillas-Bajo; Juan Salas-Felipe; Alexandre García-Escrivá; Carmen Díaz-Marín; Hugo Cabedo
Journal:  Neurol Genet       Date:  2020-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.